| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Regulatory considerations for novel gene therapy products: a review of the process leading to the first clinical lentiviral vector. | Hum Gene Ther | 2005 | 1.30 |
| 2 | ABC transporter inhibitors that are substrates enhance lentiviral vector transduction into primitive hematopoietic progenitor cells. | Blood | 2004 | 0.88 |